Brawn Biotech standalone net profit declines 32.00% in the June 2017 quarter

Capital Market 

Sales decline 24.50% to Rs 10.94 crore

Net profit of Brawn Biotech declined 32.00% to Rs 0.17 crore in the quarter ended June 2017 as against Rs 0.25 crore during the previous quarter ended June 2016. Sales declined 24.50% to Rs 10.94 crore in the quarter ended June 2017 as against Rs 14.49 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales10.9414.49 -24 OPM %1.100.76 -PBDT0.270.38 -29 PBT0.260.37 -30 NP0.170.25 -32

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)